Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients

ClinicalTrials.gov ID: NCT00677365

Public ClinicalTrials.gov record NCT00677365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Efficacy of Three Dosage Regimens of MP-376 Solution for Inhalation Given for 28 Days to Stable CF Patients

Study identification

NCT ID
NCT00677365
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
151 participants

Conditions and interventions

Interventions

  • MP-376 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2008
Primary completion
May 31, 2009
Completion
May 31, 2009
Last update posted
Dec 26, 2024

2008 – 2009

United States locations

U.S. sites
39
U.S. states
21
U.S. cities
37
Facility City State ZIP Site status
Not listed Mobile Alabama 36608
Not listed Phoenix Arizona 85016
Not listed Tucson Arizona 85724
Not listed Little Rock Arkansas 72202
Childrens Hospital Los Angeles California 90027
Not listed Los Angeles California 90033
Not listed Oakland California 94611
Not listed Orange California 92868
Not listed Palo Alto California 94304
Not listed Sacramento California 95817
Not listed San Diego California 92103
Not listed Miami Florida 33136
Not listed Orlando Florida 32801
Not listed Chicago Illinois 60025
Not listed Oak Lawn Illinois 60453
Not listed Park Ridge Illinois 60068
Not listed Iowa City Iowa 52242
Not listed Louisville Kentucky 40202
Not listed Boston Massachusetts 02115
Not listed Ann Arbor Michigan 48109
Not listed Kalamazoo Michigan 49007
Not listed Minneapolis Minnesota
Not listed Las Vegas Nevada 89107
Not listed Morristown New Jersey 07962
Not listed Albany New York 12208
Not listed Valhalla New York 10595
Not listed Cincinnati Ohio 45224
Not listed Columbus Ohio 43205
Not listed Dayton Ohio 45404
Oklahoma CF Center Oklahoma City Oklahoma 73104
Not listed Oklahoma City Oklahoma 73112
Not listed Philadelphia Pennsylvania 19102
Not listed Pittsburgh Pennsylvania 15213
Not listed Charleston South Carolina 29425
Not listed Columbia South Carolina 29203
Not listed Memphis Tennessee 38105
Not listed San Antonio Texas 78212
Not listed Tyler Texas 75708
Not listed Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00677365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 26, 2024 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00677365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →